HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis.

AbstractBACKGROUND:
Hepatoma cells are morphologically different from those of the normal liver. Intermediate filaments (IFs) are important in building the cellular architecture and maintaining the outline of cells. Plectin is a cross-linking protein that organizes the cytoskeleton into a stable meshwork, which can maintain the uniform size and shape of hepatocytes. Apoptosis might be the most possible pathway for creating plectin deficiency in the in vivo state.
MATERIALS AND METHODS:
Apoptosis was induced by staurosporine (STS) treatment in liver cells. The protein expression of cytokeratin 18 (CK18) and plectin as well as the morphology of the liver cells and the distribution of CK18 and plectin in the cells was studied after STS treatment.
RESULTS:
Plectin was cleaved in the liver cells during apoptosis and CK18 was modulated. Morphological changes were observed in the liver cells.
CONCLUSION:
By affecting the organization of IFs, plectin might play an important role in the pleomorphism of hepatoma cells and even the tumorigenesis of hepatoma.
AuthorsYi-Hsiang Liu, Chiung-Chi Cheng, Chin-Chin Ho, Wei-Ting Chao, Ren-Jeng Pei, Yung-Hsiang Hsu, Kun-Tu Yeh, Lu-Chang Ho, Ming-Chuang Tsai, Yih-Shyong Lai
JournalIn vivo (Athens, Greece) (In Vivo) 2008 Sep-Oct Vol. 22 Issue 5 Pg. 543-8 ISSN: 0258-851X [Print] Greece
PMID18853744 (Publication Type: Journal Article)
Chemical References
  • Keratin-18
  • Plectin
  • Staurosporine
Topics
  • Apoptosis (drug effects)
  • Blotting, Western
  • Fluorescent Antibody Technique
  • Humans
  • Keratin-18 (metabolism)
  • Liver (cytology, drug effects, metabolism)
  • Plectin (metabolism)
  • Staurosporine (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: